1. Home
  2. UA vs TARS Comparison

UA vs TARS Comparison

Compare UA & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc. Class C

UA

Under Armour Inc. Class C

HOLD

Current Price

$5.98

Market Cap

3.4B

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$64.42

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UA
TARS
Founded
1996
2016
Country
United States
United States
Employees
14400
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UA
TARS
Price
$5.98
$64.42
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$89.00
AVG Volume (30 Days)
2.4M
497.0K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
N/A
$55.67
Revenue Next Year
$1.72
$30.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
146.71
52 Week Low
$3.95
$38.51
52 Week High
$7.91
$85.25

Technical Indicators

Market Signals
Indicator
UA
TARS
Relative Strength Index (RSI) 40.53 37.38
Support Level $5.88 $61.11
Resistance Level $6.44 $67.70
Average True Range (ATR) 0.26 2.45
MACD -0.11 -0.98
Stochastic Oscillator 22.63 6.48

Price Performance

Historical Comparison
UA
TARS

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: